Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Our laboratory studies neuron-cancer interactions, with a focus on developmental malignancies. Using a multi-disciplinary approach within the emerging field of cancer neuroscience, we leverage ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Research at MSK Our research impact Research topics Core facilities & resources ...

Plasmacytoma (PLAZ-muh-sy-TOH-muh) is a type of cancer that starts in plasma cells. It can become multiple myeloma.

Find up-to-date information about liver metastases (secondary liver cancer) and learn about Memorial Sloan Kettering’s advances in diagnosis and treatment.

Research at MSK Our research impact Research topics Core facilities & resources ...

MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...

The most common sign of bladder cancer is blood in the urine. Learn more about what to look for and other symptoms that may be present.